Leptomeningeal Carcinomatosis Not Yet Recruiting Phase 3 Trials for Eribulin (DB08871)

IndicationStatusPhase
DBCOND0038074 (Leptomeningeal Carcinomatosis)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03613181ANG1005 in Leptomeningeal Disease From Breast CancerTreatment